Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.
about
Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death
P2860
Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging therapeutic targets f ...... d intercellular communication.
@en
type
label
Emerging therapeutic targets f ...... d intercellular communication.
@en
prefLabel
Emerging therapeutic targets f ...... d intercellular communication.
@en
P2093
P2860
P1476
Emerging therapeutic targets f ...... d intercellular communication.
@en
P2093
Annette K Brenner
Håkon Reikvam
Kimberley Joanne Hatfield
Michelle Hauge
Øystein Bruserud
P2860
P304
P356
10.1586/17474086.2015.1032935
P577
2015-04-03T00:00:00Z